Literature DB >> 31696510

Neuroanatomical correlates of the inhibition of tremulous jaw movements in rats by a combination of memantine and Δ9 -tetrahydrocannabinol.

Ilya D Ionov1, Irina I Pushinskaya2, David D Frenkel2, Niсholas P Gorev2, Larissa A Shpilevaya2.   

Abstract

BACKGROUND AND
PURPOSE: Memantine and marijuana smoking have been found to inhibit tremor in parkinsonian patients, although the observed effects were relatively weak. The tremorolytic effects of combinations of memantine and cannabinoids have not been studied. Here, we have evaluated the anti-tremor activity of memantine, Δ9 -tetrahydrocannabinol (THC) given alone and of their combination. The involvement of some neuroanatomical structures in the effects of the combination was evaluated. EXPERIMENTAL APPROACH: Haloperidol-induced tremulous jaw movements (TJMs) in rats were used as a model of parkinsonian-like tremor. To evaluate the role of central receptor systems in the drug effects, receptor ligands were administered locally into certain brain areas. KEY
RESULTS: Memantine and THC alone were without effect, although co-administration of these drugs decreased the number of haloperidol-induced jaw movements. The anti-tremor activity of the combination was antagonized (a) by injections of l-glutamate into the dorsal striatum, entopeduncular nucleus, substantia nigra pars reticulata, globus pallidus, and supratrigeminal and trigeminal motor nuclei but not into the subthalamic and cuneiform nuclei; (b) by injections of CGS 21680 into the ventrolateral striatum; and (c) by injections of bicuculline into the rostral part of the parvicellular reticular nucleus. CONCLUSIONS AND IMPLICATIONS: Memantine and THC supra-additively inhibit haloperidol-induced TJMs, suggesting that co-administration of these drugs might be a new approach to the treatment of tremor. Our results identified brain areas influencing parkinsonian-like tremor in rats and can help advance the development of novel treatments for repetitive involuntary movements.
© 2019 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31696510      PMCID: PMC7060361          DOI: 10.1111/bph.14914

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  61 in total

1.  Progression of parkinsonian signs in Parkinson disease.

Authors:  E D Louis; M X Tang; L Cote; B Alfaro; H Mejia; K Marder
Journal:  Arch Neurol       Date:  1999-03

2.  Corticostriatal functional interactions in Parkinson's disease: a rTMS/[11C]raclopride PET study.

Authors:  Antonio P Strafella; Ji Hyun Ko; Joshua Grant; Maria Fraraccio; Oury Monchi
Journal:  Eur J Neurosci       Date:  2005-12       Impact factor: 3.386

Review 3.  The functional anatomy of basal ganglia disorders.

Authors:  R L Albin; A B Young; J B Penney
Journal:  Trends Neurosci       Date:  1989-10       Impact factor: 13.837

4.  Cannabis (medical marijuana) treatment for motor and non-motor symptoms of Parkinson disease: an open-label observational study.

Authors:  Itay Lotan; Therese A Treves; Yaniv Roditi; Ruth Djaldetti
Journal:  Clin Neuropharmacol       Date:  2014 Mar-Apr       Impact factor: 1.592

5.  Pre-synaptic adenosine A2A receptors control cannabinoid CB1 receptor-mediated inhibition of striatal glutamatergic neurotransmission.

Authors:  Alberto Martire; Maria Teresa Tebano; Valentina Chiodi; Samira G Ferreira; Rodrigo A Cunha; Attila Köfalvi; Patrizia Popoli
Journal:  J Neurochem       Date:  2010-12-02       Impact factor: 5.372

6.  Effect of memantine (NMDA antagonist) on Parkinson's disease: a double-blind crossover randomized study.

Authors:  M Merello; M I Nouzeilles; A Cammarota; R Leiguarda
Journal:  Clin Neuropharmacol       Date:  1999 Sep-Oct       Impact factor: 1.592

7.  The adenosine A2A antagonist KF17837 reverses the locomotor suppression and tremulous jaw movements induced by haloperidol in rats: possible relevance to parkinsonism.

Authors:  M Correa; A Wisniecki; A Betz; D R Dobson; M F O'Neill; M J O'Neill; J D Salamone
Journal:  Behav Brain Res       Date:  2004-01-05       Impact factor: 3.332

8.  The striatum and the globus pallidus send convergent synaptic inputs onto single cells in the entopeduncular nucleus of the rat: a double anterograde labelling study combined with postembedding immunocytochemistry for GABA.

Authors:  J P Bolam; Y Smith
Journal:  J Comp Neurol       Date:  1992-07-15       Impact factor: 3.215

9.  Induction of rhythmic jaw movements by stimulation of the mesencephalic reticular formation in the guinea pig.

Authors:  N Hashimoto; T Katayama; Y Ishiwata; Y Nakamura
Journal:  J Neurosci       Date:  1989-08       Impact factor: 6.167

10.  Repeated, intermittent delta(9)-tetrahydrocannabinol administration to rats impairs acquisition and performance of a test of visuospatial divided attention.

Authors:  Christopher D Verrico; J David Jentsch; Robert H Roth; Jane R Taylor
Journal:  Neuropsychopharmacology       Date:  2004-03       Impact factor: 7.853

View more
  1 in total

1.  Neuroanatomical correlates of the inhibition of tremulous jaw movements in rats by a combination of memantine and Δ9 -tetrahydrocannabinol.

Authors:  Ilya D Ionov; Irina I Pushinskaya; David D Frenkel; Niсholas P Gorev; Larissa A Shpilevaya
Journal:  Br J Pharmacol       Date:  2020-01-24       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.